Study to assess effect of device and formulation on Pharmacokinetics (PK) of AZD1402

Trial Identifier:	D2912C00001
Sponsor:	AstraZeneca
NCTID::	NCT03921268
Start Date:	March 2019
Primary Completion Date:	June 2019
Study Completion Date:	June 2019
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version
	English UK translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.